-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Acadia Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to Q3 2025.
- Acadia Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 171M shares, a 2.69% increase year-over-year.
- Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 166M shares, a 1.55% increase from 2023.
- Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 164M shares, a 1.32% increase from 2022.
- Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 162M shares, a 0.74% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)